Literature DB >> 7896813

Location of regions of the opioid receptor involved in selective agonist binding.

K Fukuda1, S Kato, K Mori.   

Abstract

To elucidate which portions of the opioid receptor molecules are involved in the ligand selectivity, we have expressed chimeric receptors between the rat delta- and mu-opioid receptors from cDNAs and analysed their ligand binding properties. We demonstrate that the major binding determinant for the delta-selective enkephalin-related peptide, [D-Pen2,D-Pen5]enkephalin, resides within the region comprising the transmembrane segments V-VII and the intervening loop regions. On the other hand, the region spanning from the intracellular loop I to the amino-terminal half of the transmembrane segment III is shown to be involved in determining high-affinity binding of the mu-selective enkephalin-related peptides, [D-Ala2, MePhe4,Gly-ol5]enkephalin and [D-Ala2,MePhe4,Met-ol5]enkephalin, whereas the major determinant for binding of the mu-selective alkaloids, morphine and codeine, is demonstrated to exist in the region spanning the transmembrane segments V-VII. These results indicate that distinct regions of the opioid receptor determine the selectivity for the delta- and the mu-selective enkephalin-related peptides and that the binding determinant for the mu-selective alkaloids is distinct from that for the mu-selective enkephalin-related peptides.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7896813     DOI: 10.1074/jbc.270.12.6702

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  9 in total

1.  Molecular modeling study of the differential ligand-receptor interaction at the mu, delta and kappa opioid receptors.

Authors:  M Filizola; M Carteni-Farina; J J Perez
Journal:  J Comput Aided Mol Des       Date:  1999-07       Impact factor: 3.686

2.  Mutation of a conserved serine in TM4 of opioid receptors confers full agonistic properties to classical antagonists.

Authors:  P A Claude; D R Wotta; X H Zhang; P L Prather; T M McGinn; L J Erickson; H H Loh; P Y Law
Journal:  Proc Natl Acad Sci U S A       Date:  1996-06-11       Impact factor: 11.205

3.  Intense pruritus in Epstein-Barr virus (EBV) hepatitis treated with naloxone drip.

Authors:  Satyanisth Agrawal; Ryan O'Connor; Elie Aoun; Michael Babich
Journal:  BMJ Case Rep       Date:  2015-01-27

4.  The seventh transmembrane domains of the delta and kappa opioid receptors have different accessibility patterns and interhelical interactions.

Authors:  Wei Xu; Mercedes Campillo; Leonardo Pardo; J Kim de Riel; Lee-Yuan Liu-Chen
Journal:  Biochemistry       Date:  2005-12-13       Impact factor: 3.162

5.  Differential G-protein activation by alkaloid and peptide opioid agonists in the human neuroblastoma cell line SK-N-BE.

Authors:  S Allouche; J Polastron; A Hasbi; V Homburger; P Jauzac
Journal:  Biochem J       Date:  1999-08-15       Impact factor: 3.857

6.  Modeling and simulation of the human delta opioid receptor.

Authors:  Mahalaxmi Aburi; Paul E Smith
Journal:  Protein Sci       Date:  2004-07-06       Impact factor: 6.725

7.  Insights into subtype selectivity of opioid agonists by ligand-based and structure-based methods.

Authors:  Jianxin Cheng; Guixia Liu; Jing Zhang; Zhejun Xu; Yun Tang
Journal:  J Mol Model       Date:  2010-05-25       Impact factor: 1.810

8.  A new cytokine: the possible effect pathway of methionine enkephalin.

Authors:  Xin-Hua Liu; Dong-Ai Huang; Fei-Yi Yang; Yan-Sheng Hao; Guo-Guang Du; Ping-Feng Li; Gang Li
Journal:  World J Gastroenterol       Date:  2003-01       Impact factor: 5.742

9.  Studies on mu and delta opioid receptor selectivity utilizing chimeric and site-mutagenized receptors.

Authors:  W W Wang; M Shahrestanifar; J Jin; R D Howells
Journal:  Proc Natl Acad Sci U S A       Date:  1995-12-19       Impact factor: 11.205

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.